Alto Neuroscience Company

Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
Industry: Clinical Development
Headquarters: Los Altos, California, United States
Founded Date: 2019-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 9
Total Funding: 40000000
Last Funding Date: 2021-05-03
Last Funding Type: Series A

Visit Website
Register and Claim Ownership